Skip to main navigation Skip to search Skip to main content

Ursodiol does not prevent hepatic venoocclusive disease associated with Mylotarg therapy [4]

  • Francis Giles
  • , Guillermo Garcia-Manero
  • , Jorge Cortes
  • , Deborah Thomas
  • , Hagop Kantarjian
  • , Elihu Estey

Research output: Contribution to a Journal (Peer & Non Peer)Letterpeer-review

21 Citations (Scopus)
Original languageEnglish
Pages (from-to)1114-1116
Number of pages3
JournalHaematologica
Volume87
Issue number10
Publication statusPublished - Oct 2002
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Acute myeloid leukemia
  • Hepatic veno-occlusive disease
  • Mylotarg™
  • Ursodiol

Cite this